277 related articles for article (PubMed ID: 22536950)
1. A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma.
Yuan Y; Wang Q; Paulk J; Kubicek S; Kemp MM; Adams DJ; Shamji AF; Wagner BK; Schreiber SL
ACS Chem Biol; 2012 Jul; 7(7):1152-7. PubMed ID: 22536950
[TBL] [Abstract][Full Text] [Related]
2. Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells.
Yuan Y; Tang AJ; Castoreno AB; Kuo SY; Wang Q; Kuballa P; Xavier R; Shamji AF; Schreiber SL; Wagner BK
Cell Death Dis; 2013 Jun; 4(6):e690. PubMed ID: 23807219
[TBL] [Abstract][Full Text] [Related]
3. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
Lin X; Huang Y; Zou Y; Chen X; Ma X
Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel quinoline inhibitor for EHMT2/G9a through virtual screening.
Charles MRC; Mahesh A; Lin SY; Hsieh HP; Dhayalan A; Coumar MS
Biochimie; 2020 Jan; 168():220-230. PubMed ID: 31756401
[TBL] [Abstract][Full Text] [Related]
5. Targeting EHMT2/ G9a for cancer therapy: Progress and perspective.
Jan S; Dar MI; Wani R; Sandey J; Mushtaq I; Lateef S; Syed SH
Eur J Pharmacol; 2021 Feb; 893():173827. PubMed ID: 33347828
[TBL] [Abstract][Full Text] [Related]
6. Combined Targeting of G9a and Checkpoint Kinase 1 Synergistically Inhibits Pancreatic Cancer Cell Growth by Replication Fork Collapse.
Urrutia G; Salmonson A; Toro-Zapata J; de Assuncao TM; Mathison A; Dusetti N; Iovanna J; Urrutia R; Lomberk G
Mol Cancer Res; 2020 Mar; 18(3):448-462. PubMed ID: 31822519
[TBL] [Abstract][Full Text] [Related]
7. Arsenic silences hepatic PDK4 expression through activation of histone H3K9 methylatransferase G9a.
Zhang X; Wu J; Choiniere J; Yang Z; Huang Y; Bennett J; Wang L
Toxicol Appl Pharmacol; 2016 Aug; 304():42-7. PubMed ID: 27217333
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of benzimidazole derivatives as the G9a Histone Methyltransferase inhibitors that induce autophagy and apoptosis of breast cancer cells.
Zhang J; Yao D; Jiang Y; Huang J; Yang S; Wang J
Bioorg Chem; 2017 Jun; 72():168-181. PubMed ID: 28460359
[TBL] [Abstract][Full Text] [Related]
9. G9a - An Appealing Antineoplastic Target.
Chen WL; Sun HP; Li DD; Wang ZH; You QD; Guo XK
Curr Cancer Drug Targets; 2017; 17(6):555-568. PubMed ID: 27174055
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression.
Irifuku T; Doi S; Sasaki K; Doi T; Nakashima A; Ueno T; Yamada K; Arihiro K; Kohno N; Masaki T
Kidney Int; 2016 Jan; 89(1):147-57. PubMed ID: 26444031
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents.
Cao H; Li L; Yang D; Zeng L; Yewei X; Yu B; Liao G; Chen J
Eur J Med Chem; 2019 Oct; 179():537-546. PubMed ID: 31276898
[TBL] [Abstract][Full Text] [Related]
12. Insights for the design of protein lysine methyltransferase G9a inhibitors.
Charles MRC; Dhayalan A; Hsieh HP; Coumar MS
Future Med Chem; 2019 May; 11(9):993-1014. PubMed ID: 31141392
[TBL] [Abstract][Full Text] [Related]
13. G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation.
Pan MR; Hsu MC; Chen LT; Hung WC
Sci Rep; 2015 Dec; 5():18709. PubMed ID: 26688070
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel histone lysine methyltransferase G9a/GLP (EHMT2/1) inhibitors: Design, synthesis, and structure-activity relationships of 2,4-diamino-6-methylpyrimidines.
Katayama K; Ishii K; Tsuda E; Yotsumoto K; Hiramoto K; Suzuki M; Yasumatsu I; Igarashi W; Torihata M; Ishiyama T; Katagiri T
Bioorg Med Chem Lett; 2020 Oct; 30(20):127475. PubMed ID: 32781218
[TBL] [Abstract][Full Text] [Related]
15. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.
Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML
Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408
[TBL] [Abstract][Full Text] [Related]
16. Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism.
Fang S; Miao J; Xiang L; Ponugoti B; Treuter E; Kemper JK
Mol Cell Biol; 2007 Feb; 27(4):1407-24. PubMed ID: 17145766
[TBL] [Abstract][Full Text] [Related]
17. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation.
Ding J; Li T; Wang X; Zhao E; Choi JH; Yang L; Zha Y; Dong Z; Huang S; Asara JM; Cui H; Ding HF
Cell Metab; 2013 Dec; 18(6):896-907. PubMed ID: 24315373
[TBL] [Abstract][Full Text] [Related]
18. 5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.
Wozniak RJ; Klimecki WT; Lau SS; Feinstein Y; Futscher BW
Oncogene; 2007 Jan; 26(1):77-90. PubMed ID: 16799634
[TBL] [Abstract][Full Text] [Related]
19. EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors.
Souza BK; Freire NH; Jaeger M; de Farias CB; Brunetto AL; Brunetto AT; Roesler R
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681949
[TBL] [Abstract][Full Text] [Related]
20. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
